[PROLONGED DAILY STUDY OF THE SO-CALLED QUOTIENT OF REDUCING STEROIDS IN A BOY TREATED WITH HUMAN STH AND IN AN ACROMEGALIC PATIENT TREATED WITH COBALT THERAPY].
D015068:17-Ketosteroids; D000172:Acromegaly; D000305:Adrenal Cortex Hormones; D000728:Androgens; D002648:Child; D003035:Cobalt; D003036:Cobalt Isotopes; D004392:Dwarfism; D004393:Dwarfism, Pituitary; D013006:Growth Hormone; D006801:Humans; D007018:Hypopituitarism; D008297:Male; D009369:Neoplasms / Q000532:radiotherapy*; D010900:Pituitary Diseases; D010902:Pituitary Gland; D010911:Pituitary Neoplasms; D014556:Urine
D015068:17-Ketosteroids; D000305:Adrenal Cortex Hormones; D000728:Androgens; D003036:Cobalt Isotopes; D003035:Cobalt; D013006:Growth Hormone
17-KETOSTEROIDS; ACROMEGALY; ADRENAL CORTEX HORMONES; ANDROGENS; CHILD; COBALT ISOTOPES; DWARFISM, PITUITARY; HYPOPITUITARISM; NEOPLASM RADIOTHERAPY; PITUITARY NEOPLASMS; SOMATOTROPIN; URINE
STUDIO GIORNALIERO PROTRATTO DEL COS'I DETTO QUOZIENTE DEGLI STEROIDI RIDUCENTI IN UN RAGAZZO TRATTATO CON STH UMANO E IN UN ACROMEGALICO TRATTATO CON COBALTOTERAPIA.